|CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368|
November 07, 2012
Health Tip: Mouth Piercings Can Be Dangerous
(HealthDay News) -- Before you adorn your tongue, lips or other parts of your mouth with jewelry, experts say you should consider the potential dangers.
Health Tip: Preventing Excess Gas
(HealthDay News) -- Excess gas in the digestive tract can make you feel bloated and uncomfortable.
Programming Change in Defibrillator Implants May Lower Death Risk: Study
WEDNESDAY, Nov. 7 (HealthDay News) -- A simple change to the way doctors program implantable cardioverter defibrillators can help people with heart disease live longer and with greater quality of life, according to a new study.
Mother's Menopause May Influence Her Daughter's Fertility
WEDNESDAY, Nov. 7 (HealthDay News) -- A mother's age at menopause may predict her daughter's fertility in terms of eggs remaining in her ovaries, a new study suggests.
Body Temperature May Matter After Cardiac Arrest
WEDNESDAY, Nov. 7 (HealthDay News) -- Lowering the body temperature of people who have been resuscitated following cardiac arrest may increase their chances of survival, according to a new study.
Women Don't Fare as Well as Men With Implanted Defibrillators: Study
WEDNESDAY, Nov. 7 (HealthDay News) -- Women are more likely than men to experience complications and to die within six months of getting an implantable cardioverter defibrillator, according to new research that looked at nearly 39,000 patients.
Pregnancy Hormone Shows Promise as Heart Failure Drug
WEDNESDAY, Nov. 7 (HealthDay News) -- A synthetic form of a hormone that ramps up during pregnancy might prove to be a powerful new drug against tough-to-treat heart failure.
Report Details Start of Steroid Meningitis Outbreak
WEDNESDAY, Nov. 7 (HealthDay News) -- The first reports of serious fungal infections from tainted steroid injections for back pain came in September from Tennessee and quickly became a national health crisis.
Xeljanz Approved for Rheumatoid Arthritis
WEDNESDAY, Nov. 7 (HealthDay News) -- Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.
Health Highlights: Nov. 7, 2012
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.